首页|西酞普兰与阿普唑仑治疗广泛性焦虑症的疗效与不良反应分析

西酞普兰与阿普唑仑治疗广泛性焦虑症的疗效与不良反应分析

扫码查看
目的 探究西酞普兰与阿普唑仑治疗广泛性焦虑症的疗效与不良反应.方法 88 例广泛性焦虑症患者,以就诊病历尾号奇偶数法分为参照组和试验组,每组 44 例.参照组采用阿普唑仑治疗,试验组采用西酞普兰治疗.对比两组临床疗效、睡眠质量、焦虑情绪及不良反应发生率.结果 治疗 6 周后,试验组和参照组总有效率分别为 95.45%、90.91%,对比差异无统计学意义(P>0.05).治疗 6 周后,试验组睡眠质量、睡眠效率、入睡时间、睡眠障碍、睡眠时间、催眠药物、日间功能障碍评分分别为(1.12±0.04)、(0.53±0.11)、(1.21±0.12)、(1.22±0.26)、(0.71±0.14)、(0.45±0.12)、(0.48±0.34)分,低于参照组的(1.36±0.16)、(0.88±0.14)、(1.58±0.23)、(1.69±0.28)、(1.23±0.31)、(1.15±0.15)、(1.22±0.36)分,差异有统计学意义(P<0.05).治疗后 1、2、4、6 周,试验组患者焦虑自评量表(SAS)评分与参照组对比,差异无统计学意义(P>0.05).试验组不良反应发生率为 4.55%,较参照组的 27.27%明显降低,差异有统计学意义(P<0.05).结论 针对广泛性焦虑患者,分别给予西酞普兰与阿普唑仑进行治疗后临床疗效相当,均可有效改善焦虑情绪,但是与阿普唑仑相比,西酞普兰治疗广泛性焦虑症更能显著改善患者睡眠质量,且不良反应少,值得在临床上广泛推广应用.
Analysis of efficacy and adverse reactions of citalopram and alprazolam in the treatment of generalized anxiety disorder
Objective To explore the efficacy and adverse reactions of citalopram and alprazolam in the treatment of generalized anxiety disorder.Methods A total of 88 patients with generalized anxiety disorder were divided into the reference group and the experimental group according to odd or even number at the end of medical record,with 44 cases in each group.The reference group was treated with alprazolam,and the experimental group was treated with citalopram.The clinical efficacy,sleep quality,anxiety and incidence of adverse reactions were compared between the two groups.Results After 6 weeks of treatment,the total effective rate of the experimental group and the reference group were 95.45%and 90.91%,the difference was not statistically significant(P>0.05).After 6 weeks of treatment,the scores of sleep quality,sleep efficiency,sleep latency,sleep disorder,sleep time,hypnotic drugs and daytime dysfunction in the experimental groups were(1.12±0.04),(0.53±0.11),(1.21±0.12),(1.22±0.26),(0.71±0.14),(0.45±0.12)and(0.48±0.34)points,which were lower than(1.36±0.16),(0.88±0.14),(1.58±0.23),(1.69±0.28),(1.23±0.31),(1.15±0.15)and(1.22±0.36)points in the reference group.The difference was statistically significant(P<0.05).After 1,2,4 and 6 weeks of treatment,there was no significant difference in self-rating anxiety scale(SAS)score between the experimental group and the reference group(P>0.05).The incidence of adverse reactions in the experimental group was 4.55%,which was significantly lower than 27.27%in the reference group,and the difference was statistically significant(P<0.05).Conclusion For patients with generalized anxiety disorder,the clinical efficacy of citalopram and alprazolam is comparable,and both can effectively improve anxiety.However,compared with alprazolam,citalopram can significantly improve the sleep quality of patients with generalized anxiety disorder and has fewer adverse reactions,so it is worth widely promoting and applying in clinical practice.

CitalopramAlprazolamGeneralized anxiety disorderEfficacyAdverse reactions

张瑞刚

展开 >

276000 临沂市中心医院

西酞普兰 阿普唑仑 广泛性焦虑症 疗效 不良反应

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(7)
  • 20